VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics Inc Common Stock (CGEM)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
CGEM
Shares outstanding
59,102,912 shares
Disclosed Ownership
2,943,325 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
30 Oct 2025, 14:57:38 UTC
Date of event
30 Sep 2025
Next filing
30 Jan 2026

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 5% 2,943,325 0 331,445 Ashley Grim Head of Global Fund Administration